Basecamp Wealth Advisors’s Fresenius Medical Care FMS Stock Holding History
Bought
Maintained
Sold
Other funds holding FMS
FMI
BIP
TAM
TRSOTSOK
Basecamp Wealth Advisors's FMS Position: Q2 2026 in Review
Basecamp Wealth Advisors increased its Fresenius Medical Care (FMS) stake by 8% in Q2 2026, buying an estimated $471 and bringing the position to 285 shares worth $6.44K. The position accounts for ﹤0.01% of the portfolio, ranked #1114.
Basecamp Wealth Advisors first reported a position in FMS in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.79K in Q4 2025. 233 funds tracked by Wall St. Rank hold FMS as of Q2 2026.
- Basecamp Wealth Advisors held 285 shares of Fresenius Medical Care worth $6.44K as of Q2 2026.
- Basecamp Wealth Advisors bought 21 Fresenius Medical Care shares in Q2 2026, an estimated $471.
- Fresenius Medical Care made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1114 holding.
- Basecamp Wealth Advisors first reported a position in Fresenius Medical Care in Q4 2025 and has held it in 3 quarters since.
- Basecamp Wealth Advisors's Fresenius Medical Care position peaked at $6.79K in Q4 2025.
- 233 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.
Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.